WASHINGTON INSTITUTE FOR COAGULATION
Data sourced from IRS 990 public filings
WASHINGTON INSTITUTE FOR COAGULATION THE WASHINGTON CENTER FOR BLEEDING DISORDERS (WACBD) IS DEDICATED TO SECURE, PROMOTE AND PROTECT OPTIMAL HEALTH FOR PEOPLE WITH BLEEDING DISORDERS THROUGH COMPREHENSIVE CARE, EDUCATION AND RESEARCH IN PARTNERSHIP WITH OUR PATIENTS, THEIR FAMILIES, AND THE LOCAL AND NATIONAL BLEEDING DISORDERS COMMUNITY.
WASHINGTON INSTITUTE FOR COAGULATION has received 3 grants from 2 known foundation funders. Revenue decreased from $122,490,634 in 2023 to $112,675,357 in 2024. Most recent reported revenue: $112,675,357.
Annual Revenue
$112,675,357
Known Funders
2
Grants Received
3
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $112,675,357 | $101,694,334 | $87,751,207 |
| 2023 | $122,490,634 | $108,898,367 | $78,674,468 |
| 2022 | $114,481,287 | $104,365,786 | $74,267,913 |
| 2021 | $104,303,330 | $95,835,264 | $62,548,021 |
| 2020 | $23,307,124 | $5,320,012 | $22,969,975 |
Top Funders
SEATTLE, WA
SEATTLE, WA
SEATTLE, WA
Key Personnel
From 2024 IRS 990 filing
REBECCA KRUSE-JARRES MD
EXECUTIVE/MEDICAL DIRECTOR
NEIL JOSEPHSON MD
PRESIDENT
KRISHNA JAFA
VICE PRESIDENT
KRISTIAN PRILL HAMILTON
BOARD MEMBER
ROSHNI KULKARNI
BOARD MEMBER
LORI JACOBSEN-TEWS
BOARD MEMBER
SETHU MEIYAPPAN
BOARD MEMBER
KIM SNYDER
CFO/COO (THRU 11/24)/BOARD TREASURER
EVA SZYSZKA
CFO/COO
HSIN KAI A CHEN
PHARMACY DIRECTOR
Showing 10 of 15 key personnel.
Frequently Asked Questions
Other Nonprofits in Washington
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.